Expert Opinion on Pharmacotherapy

Efficacy and costs of secondary prevention with antiplatelets after ischaemic stroke
pp. 359-367(9)
Authors: Ringleb Peter A; Schwark Christian; Schwaninger Markus; Schellinger Peter D

The economic burden of depression in the US: societal and patient perspectives
pp. 369-376(8)
Authors: Greenberg Paul E; Birnbaum Howard G

Therapy of porphyria cutanea tarda
pp. 377-383(7)
Authors: Köstler Erich; Wollina Uwe

Pharmacological management of paracoccidioidomycosis
pp. 385-397(13)
Author: Shikanai Yasuda Maria Aparecida

Treatment of hepatitis C: critical appraisal of the evidence
pp. 399-408(10)
Authors: Cammà Calogero; Licata Anna; Cabibbo Giuseppe; Latteri Federica; Craxì Antonio

Acne vulgaris: a review of antibiotic therapy
pp. 409-418(10)
Authors: Tan Audrey W; Tan Hiok-Hee

Pharmacological treatment of disabling tremor
pp. 419-428(10)
Authors: Schadt Courtney R; Duffis Ennis I; Charles P David

The use of darbepoetin alfa for the treatment of chemotherapy-induced anaemia
pp. 429-440(12)
Authors: Vansteenkiste Johan; Wauters Isabelle

Cinacalcet HCl: a novel therapeutic for hyperparathyroidism
pp. 441-452(12)
Author: de Francisco Angel LM

Enfuvirtide: the first HIV fusion inhibitor
pp. 453-464(12)
Author: Lazzarin Adriano

Risedronate for prevention and treatment of osteoporosis in postmenopausal women
pp. 465-477(13)
Authors: Recker Robert R; Barger-Lux Janet

Sirolimus: a new option in transplantation
pp. 479-487(9)
Author: Mota Alfredo

The first 5years of clinical experience with laronidase enzyme replacement therapy for mucopolysaccharidosis I
pp. 489-506(18)
Author: Wraith J E

VALIANT (VALsartan In Acute myocardial iNfarcTion) trial
pp. 507-512(6)
Authors: Maggioni Aldo Pietro; Fabbri Gianna

CHARMed – the effects of candesartan in heart failure
pp. 513-516(4)
Author: Doggrell Sheila A

The therapeutic potential of vasopressin in cardiopulmonary resuscitation
pp. 517-520(4)
Author: Salam Amar Mohammad